JPMorgan Chase & Co’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.83M | Sell |
783,927
-23,838
| -3% | -$269K | ﹤0.01% | 2308 |
|
|
2025
Q1 | $8.15M | Buy |
807,765
+39,276
| +5% | +$396K | ﹤0.01% | 2326 |
|
|
2024
Q4 | $9.09M | Sell |
768,489
-54,093
| -7% | -$640K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $9.49M | Buy |
822,582
+34,453
| +4% | +$398K | ﹤0.01% | 2193 |
|
|
2024
Q2 | $8.33M | Sell |
788,129
-135,673
| -15% | -$1.43M | ﹤0.01% | 2215 |
|
|
2024
Q1 | $9.74M | Buy |
923,802
+501,362
| +119% | +$5.28M | ﹤0.01% | 2141 |
|
|
2023
Q4 | $4.74M | Sell |
422,440
-146,680
| -26% | -$1.65M | ﹤0.01% | 2601 |
|
|
2023
Q3 | $6.65M | Buy |
569,120
+238,303
| +72% | +$2.78M | ﹤0.01% | 2258 |
|
|
2023
Q2 | $3.33M | Sell |
330,817
-9,941
| -3% | -$100K | ﹤0.01% | 2741 |
|
|
2023
Q1 | $2.51M | Buy |
340,758
+266,464
| +359% | +$1.97M | ﹤0.01% | 2905 |
|
|
2022
Q4 | $593K | Buy |
74,294
+33,534
| +82% | +$268K | ﹤0.01% | 3664 |
|
|
2022
Q3 | $131K | Buy |
40,760
+2,866
| +8% | +$9.21K | ﹤0.01% | 4358 |
|
|
2022
Q2 | $154K | Buy |
+37,894
| New | +$154K | ﹤0.01% | 4439 |
|